1.48
0.00 (0.00%)
| Penutupan Terdahulu | 1.48 |
| Jumlah Dagangan | 26,251 |
| Harga / Jualan (P/S) | 2.22 |
| Harga / Buku (P/B) | 0.590 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -19,230.14% |
| EPS Cair (TTM) | -1.47 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -28.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.42% |
| Nisbah Semasa (MRQ) | 2.24 |
| Aliran Tunai Operasi (OCF TTM) | -8.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.84 M |
| Pulangan Atas Aset (ROA TTM) | -54.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -117.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | BioRestorative Therapies, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.1 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -0.3 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.19 |
|
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 25.54% |
| % Dimiliki oleh Institusi | 12.62% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Wealth Alliance, Llc | 30 Jun 2026 | 2,000 |
| Keystone Financial Group | 30 Jun 2026 | 1,430 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |